Healthy Skepticism Library item: 6589

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Vitry A.
Rhône-Poulenc Rorer claims that their promotional material “is well balanced and answers the needs of the clinician with regard to both safety and efficacy”
MaLAM Australian News 1995 Jun; 3:(6):1-4

Abstract:

Rhone-Poulenc Rorer has responded to MaLAM’s earlier critique of its promotional practices concerning Orudis SR (ketoprofen). MaLAM analyzes the responses and comments on them. MaLAM concludes that the answers from Rhone-Poulenc Rorer did not provide any convincing evidence to support the company’s claims about Orudis SR.

Keywords:
*analysis/Australia/developed countries/Orudis SR/ketoprofen/Rhone-Poulenc/NSAID/ nonsteroidal anti-inflammatory drugs/ industry perspective/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ATTITUDES REGARDING PROMOTION: INDUSTRY/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES